» Articles » PMID: 35903328

Number 2 Feibi Recipe Ameliorates Pulmonary Fibrosis by Inducing Autophagy Through the GSK-3β/mTOR Pathway

Overview
Journal Front Pharmacol
Date 2022 Jul 29
PMID 35903328
Authors
Affiliations
Soon will be listed here.
Abstract

Number 2 Feibi Recipe (N2FBR) is a traditional Chinese medicine formula for treating idiopathic pulmonary fibrosis. N2FBR inhibits HO-mediated oxidative stress damage in alveolar epithelial cells by increasing autophagy, as we previously demonstrated. However, it is unknown if similar mechanisms occur . We established a pulmonary fibrosis model by instilling bleomycin (BLM) from the airway to examine the effects of N2FBR on pulmonary fibrosis and investigate its probable mechanism in this work. We discovered that N2FBR treatment effectively alleviated interstitial fibrosis as well as collagen deposition, primarily in upregulating SOD, GSH-Px, T-AOC and downregulating MDA content. N2FBR also increased the expression of LC3B, Beclin-1, LAMP1, TFEB and downregulated the expression of p62, legumain. N2FBR treatment boosted the production of autophagosomes, according to the results of the TEM observation. Furthermore, we explored that N2FBR exerted its anti-oxidative stress and pro-autophagy effects via GSK-3β/mTOR signalling pathway. Therefore, these results provide further evidence for the protective effect of N2FBR in pulmonary fibrosis. Our findings could have ramifications for the development of antifibrosis therapies.

Citing Articles

Serum legumain is a potential biomarker for community-acquired pneumonia: a prospective cohort study.

Meng X, Ma K, Qu K, Cheng Z, Fu L, Qu Y Int J Med Sci. 2025; 22(5):1072-1080.

PMID: 40027188 PMC: 11866532. DOI: 10.7150/ijms.106118.


FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis.

Cheng Y, Jiao Y, Wei W, Kou M, Cai Y, Li Y Front Pharmacol. 2025; 16:1509665.

PMID: 40008127 PMC: 11850536. DOI: 10.3389/fphar.2025.1509665.


Silicosis: from pathogenesis to therapeutics.

Yang B, Liu X, Peng C, Meng X, Jia Q Front Pharmacol. 2025; 16:1516200.

PMID: 39944632 PMC: 11813918. DOI: 10.3389/fphar.2025.1516200.


Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway.

Attia S, Saadawy S, El-Mahroky S, Nageeb M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5953-5974.

PMID: 38376539 PMC: 11329427. DOI: 10.1007/s00210-024-03004-y.


Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats.

Ge S, Guo Z, Xiao T, Sun P, Yang B, Ying Y Mediators Inflamm. 2024; 2024:5573353.

PMID: 38361765 PMC: 10869187. DOI: 10.1155/2024/5573353.


References
1.
Akhtar M, Alhadlaq H, Alshamsan A, Khan M, Ahamed M . Aluminum doping tunes band gap energy level as well as oxidative stress-mediated cytotoxicity of ZnO nanoparticles in MCF-7 cells. Sci Rep. 2015; 5:13876. PMC: 4561961. DOI: 10.1038/srep13876. View

2.
Jiang P, Mizushima N . LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods. 2014; 75:13-8. DOI: 10.1016/j.ymeth.2014.11.021. View

3.
Wang W, Liu Z, Niu J, Yang H, Long Q, Liu H . Feibi Recipe Reduced Pulmonary Fibrosis Induced by Bleomycin in Mice by Regulating BRP39/IL-17 and TGF1/Smad3 Signal Pathways. Evid Based Complement Alternat Med. 2020; 2020:5814658. PMC: 7576352. DOI: 10.1155/2020/5814658. View

4.
Summer R, Shaghaghi H, Schriner D, Roque W, Sales D, Cuevas-Mora K . Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium. Am J Physiol Lung Cell Mol Physiol. 2019; 316(6):L1049-L1060. PMC: 6620667. DOI: 10.1152/ajplung.00244.2018. View

5.
Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes C, Valko M . Targeting Free Radicals in Oxidative Stress-Related Human Diseases. Trends Pharmacol Sci. 2017; 38(7):592-607. DOI: 10.1016/j.tips.2017.04.005. View